43.24
Agios Pharmaceuticals Inc (AGIO) 最新ニュース
What earnings revisions data tells us about Agios Pharmaceuticals Inc.2025 Earnings Surprises & Technical Pattern Recognition Alerts - newser.com
How Agios Pharmaceuticals Inc. (8AP) stock correlates with oil marketsJuly 2025 Outlook & Daily Growth Stock Investment Tips - newser.com
What drives Agios Pharmaceuticals Inc stock priceMarket Capitalization Trends & High Return Capital Strategies - earlytimes.in
Will Agios Pharmaceuticals Inc. benefit from macro trendsMarket Volume Summary & Target Return Focused Stock Picks - newser.com
Institutional scanner results for Agios Pharmaceuticals Inc.Bond Market & Weekly Chart Analysis and Trade Guides - newser.com
Is it time to cut losses on Agios Pharmaceuticals Inc.July 2025 Sector Moves & Consistent Profit Trade Alerts - newser.com
What data driven models say about Agios Pharmaceuticals Inc.’s future - newser.com
Is Agios Pharmaceuticals Inc. stock supported by strong cash flows2025 Bull vs Bear & Verified Entry Point Detection - newser.com
Can Agios Pharmaceuticals Inc. stock deliver sustainable ROEBuy Signal & Consistent Return Investment Signals - newser.com
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Savvy Advisors Inc. Takes Position in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
Published on: 2025-11-02 02:45:06 - newser.com
Candlestick signals on Agios Pharmaceuticals Inc. stock todayQuarterly Market Summary & Reliable Price Action Trade Plans - newser.com
Is Agios Pharmaceuticals Inc. (8AP) stock among top earnings playsMarket Activity Summary & Daily Technical Stock Forecast Reports - newser.com
Agios Pharmaceuticals Q3 2025 Earnings Preview - MSN
Agios outlines Q4 2025 PYRUKYND milestones and anticipates U.S. thalassemia approval amid global expansion - MSN
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q3 2025 Earnings Call Transcript - Insider Monkey
RBC Capital Keeps Their Buy Rating on Agios Pharma (AGIO) - The Globe and Mail
Published on: 2025-11-01 04:26:21 - newser.com
Agios Pharmaceuticals’ Earnings Call: Growth and Challenges - MSN
AGIO's Q3 Loss Narrower Than Expected, Pyrukynd Drives Y/Y Revenues - sharewise.com
Agios Pharmaceuticals (NASDAQ:AGIO) Issues Quarterly Earnings Results, Beats Expectations By $0.15 EPS - MarketBeat
High Growth Tech Stocks In The US Market With Promising Potential - simplywall.st
Can Agios Pharmaceuticals Inc. stock surprise with earnings upsideGap Down & Comprehensive Market Scan Reports - newser.com
Agios Pharmaceuticals (AGIO) Reports Q3 Loss, Beats Revenue Estimates - sharewise.com
Decoding Agios Pharmaceuticals Inc (AGIO): A Strategic SWOT Insi - GuruFocus
Agios Pharmaceuticals: Q3 Earnings Snapshot - CT Insider
Agios Pharmaceuticals Inc (AGIO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... By GuruFocus - Investing.com Canada
Agios Pharmaceuticals, Inc. (AGIO) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sarah Gheuens Sells 3,302 Shares - MarketBeat
Agios Pharmaceuticals Inc (AGIO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo! Finance Canada
Earnings Call Summary | Agios Pharmaceuticals(AGIO.US) Q3 2025 Earnings Conference - 富途牛牛
Transcript : Agios Pharmaceuticals, Inc., Q3 2025 Earnings Call, Oct 30, 2025 - MarketScreener
大文字化:
|
ボリューム (24 時間):